Are uterine transplants from a deceased donor ethical?

The first ever livebirth via a transplanted uterus from a deceased donor occurred last December. The transplantation occurred in September 2016 in Brazil. Uterine transplants have occurred from living donor to recipient, and in 2013 the first ever live birth from a uterus transplant occurred. Women who want to receive a uterus transplant from a living donor can only do so from a relative who is willing to donate, but with the success of using a deceased donor, more infertile women may be eligible for uterine transplant. With the successful transplantation, impregnation, and birthing from a deceased donor uterus, new ethical arguments are soon to be formulated. The physician-researchers who performed the procedure noted the research associated with deceased donor uterine transplants is still minimal, so more studies still need to be conducted to fully understand the risks associated with this procedure. However, they are confident that in the future the procedure will be more widely used because it removes risk to a living patient when removing the organ (because the donor is deceased) and will make a donor uterus more accessible to women.

I personally do not see any problem with the donation of a uterus from a deceased donor. If the individual has consented to be an organ donor prior to dying, then donation of her uterus would be equivalent to donation of her kidneys, heart, etc. From a beneficence standpoint, this procedure can allow women who are unable to conceive a child due to complications of their uterus to have the ability to possibly do so. This procedure does no harm to the donor, since they are currently deceased, and can potentially help another individual achieve pregnancy. The only initial drawback I see with this procedure, right now, is cost of the procedure. Currently, in the U.S. a uterus transplant is estimated to cost between $150,000 and $500,000 and is not covered by insurance. Hopefully, as the procedure becomes researched more, the cost will be decreased, and maybe even covered by insurance. There is a lot of potential with uterine transplants so they should be researched more.

References:
https://www.sciencedaily.com/releases/2018/12/181204183703.htm